EMILY MEYERHOFFER: Open Payments
NPI 1073275434 · PLEASANT VIEW, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 23 payments from 17 companies in 2025. Trend: 2023 $302 · 2024 $139 · 2025 $417
Food & beverage: $417
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $55 |
| PFIZER INC. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Axsome Therapeutics, Inc. | 2 | $30 |
| Novo Nordisk Inc | 2 | $30 |
| Baxter Healthcare | 1 | $30 |
| Amgen Inc. | 1 | $27 |
| Corium, LLC | 1 | $20 |
| Indivior Inc. | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
Products named: TRELEGY ELLIPTA, Auvelity, Hillrom - Cardiac Ambulatory Monitor, EVENITY, NURTEC ODT, Azstarys, SUBLOCADE, VOWST.
Industry payments across UT — which companies pay providers there.
